Data-driven Analysis of TRP Channels in Cancer: Linking Variation in Gene Expression to Clinical Significance

Yu Rang Park1, Jung Nyeo Chun2, Insuk So2

  • 1Office of Clinical Research Information, Asan Medical Center, Seoul, Republic of Korea.

Abstract

Insights

Transient receptor potential (TRP) channels are implicated in cancer, but their clinical roles are unclear. This study reveals TRP channel gene expression variations across cancers, highlighting their diagnostic and prognostic potential.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Background:

  • Transient receptor potential (TRP) channels are increasingly recognized for their role in tumor biology.
  • The clinical significance and specific involvement of TRP channels in various human cancers remain largely undetermined.

Purpose of the Study:

  • To investigate the expression patterns of 27 TRP channel genes across 14 distinct human cancer types.
  • To identify potential diagnostic and prognostic biomarkers among TRP channels in cancer.

Main Methods:

  • Utilized a data-driven approach analyzing International Cancer Genome Consortium (ICGC) data.
  • Dissected the expression landscape of 27 TRP channel genes in 14 human cancer types.

Main Results:

  • TRPM2 showed overexpression in most tumors; TRPM3 was broadly downregulated.
  • TRPV4 and TRPA1 exhibited cancer type-specific up- and downregulation, respectively.
  • TRPC4 associated with head and neck cancer incidence and kidney cancer patient survival; TRPM8 and TRPP1 identified as potential diagnostic/prognostic markers for lung and kidney cancers.

Conclusions:

  • TRP channel gene expression varies significantly across different cancer types and specific genes.
  • Certain TRP channels demonstrate strong potential as predictive diagnostic and prognostic markers in oncology.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.9K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

6.1K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

3.0K